Japan Seeks Criminal Probe of Novartis on Hypertension Drug
This article is for subscribers only.
Japan’s health ministry filed a complaint with Tokyo prosecutors against Novartis AG, seeking a criminal investigation of the company for possibly breaching advertising rules with its Diovan hypertension drug.
The complaint accuses Novartis of exaggerating Diovan’s effectiveness in marketing materials, according to a statement on the agency’s website. Novartis will fully cooperate with Japanese authorities, the Basel, Switzerland-based company said in a statement today.